Doctor profile · Federal record

Dr. Padma Chimata, M.D.

Rheumatology Physician (CMS: Rheumatology) · Katy, TX

  • NPI 1922297068
  • Accepts Medicare
  • MIPS 96.2 / 100 · 2023
  • 27 yrs in practice
  • Female
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
402 Park Grove Drive
Katy, TX 774501571
(281) 578-7438

Credentials & registration

NPPES · NUCC
NPI registered
October 2007 — 19 yrs on file
Profile last updated
June 30, 2022
Year of graduation
1999 — 27 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Texas #M7112

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1922297068. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
111,571
Distinct HCPCS
10
Medicare allowed
$1,674,196
HCPCS Description Services Patients Avg allowed
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 56,000 17 $5
J3111 Injection, romosozumab-aqqg, 1 mg 13,860 12 $10
J1602 Injection, golimumab, 1 mg, for intravenous use 12,800 13 $13
J0897 Injection, denosumab, 1 mg 10,980 100 $23
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 9,750 15 $42
J7322 Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg 2,232 28 $17
99214 Established patient office or other outpatient visit, 30-39 minutes 1,727 566 $131
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 1,560 129 $1
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 597 125 $75
J7050 Infusion, normal saline solution, 250 cc 486 39 $1

In context: peer comparison

Among 5 peers in this city , average services per provider: 5,088. This provider delivers 22× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$8,402
Transactions
120
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Amgen Inc. 29 $6,124.44
AstraZeneca Pharmaceuticals LP 12 $367.11
UCB, Inc. 14 $319.03
ABBVIE INC. 10 $219.82
ANI Pharmaceuticals, Inc. 8 $202.70
Janssen Biotech, Inc. 10 $197.78
GENZYME CORPORATION 4 $143.29
PFIZER INC. 11 $141.24
Aurinia Pharma U.S., Inc. 6 $111.91
Alexion Pharmaceuticals, Inc. 4 $110.67
Octapharma USA, Inc. 1 $94.74
Sandoz Inc. 3 $77.24
Novartis Pharmaceuticals Corporation 3 $71.12
Almatica Pharma LLC 3 $54.05
Lilly USA, LLC 2 $40.08

By nature of payment

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
$5,400
Food and Beverage
$2,884
Education
$71
Travel and Lodging
$47

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
4,087
Patients
1,391
Total drug cost
$132,334
Drug Type Claims Patients Total cost
Hydroxychloroquine Sulfate Generic 814 249 $61,076
Prednisone Generic 622 259 $4,083
Methotrexate (Methotrexate Sodium) Brand 611 184 $27,234
Gabapentin Generic 459 165 $7,312
Meloxicam Generic 250 100 $1,329
Alendronate Sodium Generic 234 70 $2,737
Duloxetine Hcl Generic 199 74 $6,071
Leflunomide Generic 151 44 $9,907
Allopurinol Generic 146 42 $3,382
Celecoxib Generic 137 49 $4,051

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Padma Chimata's medical specialty?
Dr. Padma Chimata practices Rheumatology Physician in Katy, TX.
Where does Dr. Padma Chimata practice?
Dr. Padma Chimata practices at 402 Park Grove Drive, Katy, TX 774501571. Office phone: 2815787438.
What is Dr. Padma Chimata's NPI?
Dr. Padma Chimata's National Provider Identifier (NPI) is 1922297068, issued by NPPES.
Does Dr. Padma Chimata accept Medicare assignment?
Yes. Dr. Padma Chimata accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Padma Chimata commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.